Abstract
The four members of the ErbB family of receptor tyrosine kinases (RTKs) mediate a variety of cellular responses to epidermal growth factor (EGF)-like growth factors, and serve as a model for the generation of both diversity and specificity in RTK signaling. Previous studies indicate that receptor–receptor interactions figure prominently in signaling through ErbB receptors. In addition to a role in receptor kinase activation, ligand-induced ErbB receptor homo- and heterodimerization is thought to account for the diversity of biological responses stimulated by EGF-like growth factors. Since each receptor has the potential to couple to different complements of signaling pathways, EGF-like ligands specify cellular response by dictating which pairs of receptors become activated. More recently evidence has been uncovered for ligand discrimination by individual ErbB receptor dimers; receptors appear to realize which ligand is binding and differentially respond through autophosphorylation site usage. These observations indicate that ligand stimulation of RTKs is not generic, and point to another layer in the ErbB signal diversification mechanism. The mechanistic implications of ligand discrimination are discussed.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Alroy I and Yarden Y. . 1997 FEBS Lett. 410: 83–86.
Burden S and Yarden Y. . 1997 Neuron 18: 847–855.
Burke CL, Lemmon MA, Coren BA, Engelman DM and Stern DF. . 1997 Oncogene 14: 687–696.
Burke CL and Stern DF. . 1998 Mol. Cell. Biol. 18: 5371–5379.
Carraway KL III and Cantley LC. . 1994 Cell 78: 5–8.
Carraway KL III, Rossi EA, Komatsu M, Price-Schiavi SA, Huang D, Guy PM, Carvajal ME, Fregien N, Carraway CA and Carraway KL. . 1999 J. Biol. Chem. 274: 5263–5266.
Chan FK, Chun HJ, Zheng L, Siegel RM, Bui KL and Lenardo MJ. . 2000 Science 288: 2351–2354.
Crovello CS, Lai C, Cantley LC and Carraway KL III. . 1998 J. Biol. Chem. 273: 26954–26961.
Day RM, Cioce V, Breckenridge D, Castagnino P and Bottaro DP. . 1999 Oncogene 18: 3399–3406.
Dodge K and Scott JD. . 2000 FEBS Lett. 476: 58–61.
Follenzi A, Bakovic S, Gual P, Stella MC, Longati P and Comoglio PM. . 2000 Oncogene 19: 3041–3049.
Fujioka Y, Matozaki T, Noguchi T, Iwamatsu A, Yamao T, Takahashi N, Tsuda M, Takada T and Kasuga M. . 1996 Mol. Cell. Biol. 16: 6887–6899.
Gamett DC, Pearson G, Cerione RA and Friedberg I. . 1997 J. Biol. Chem. 272: 12052–12056.
Ghiglione C, Carraway KL III, Amundadottir LT, Boswell RE, Perrimon N and Duffy JB. . 1999 Cell 96: 847–856.
Graus-Porta D, Beerli RR, Daly JM and Hynes NE. . 1997 EMBO J. 16: 1647–1655.
Guy PM, Platko JV, Cantley LC, Cerione RA and Carraway KL III. . 1994 Proc. Natl. Acad. Sci. USA 91: 8132–8136.
Heldin CH. . 1995 Cell 80: 213–223.
Huang GC, Ouyang X and Epstein RJ. . 1998 Biochem. J. 331: 113–119.
Hubbard SR, Mohammadi M and Schlessinger J. . 1998 J. Biol. Chem. 273: 11987–11990.
Jiang G and Hunter T. . 1999 Curr. Biol. 9: R568–R571.
Karunagaran D, Tzahar E, Beerli RR, Chen X, Graus-Porta D, Ratzkin BJ, Seger R, Hynes NE and Yarden Y. . 1996 EMBO J. 15: 254–264.
Kharitonenkov A, Chen Z, Sures I, Wang H, Schilling J and Ullrich A. . 1997 Nature 386: 181–186.
LaRochelle WJ, Sakaguchi K, Atabey N, Cheon HG, Takagi Y, Kinaia T, Day RM, Miki T, Burgess WH and Bottaro DP. . 1999 Biochemistry 38: 1765–1771.
Lesa GM and Sternberg PW. . 1997 Mol. Biol. Cell. 8: 779–793.
Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK and Wilson IA. . 1999 Science 283: 987–990.
Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA and Di Fiore PP. . 1990 New Biol. 2: 992–1003.
Margolis B. . 1992 Cell Growth Differ. 3: 73–80.
Murali R, Brennan PJ, Kieber-Emmons T and Greene MI. . 1996 Proc. Natl. Acad. Sci. USA 93: 6252–6257.
Ochi F, Matozaki T, Noguchi T, Fujioka Y, Yamao T, Takada T, Tsuda M, Takeda H, Fukunaga K, Okabayashi Y and Kasuga M. . 1997 Biochem. Biophys. Res. Commun. 239: 483–487.
Olayioye MA, Graus-Porta D, Beerli RR, Rohrer J, Gay B and Hynes NE. . 1998 Mol. Cell. Biol. 18: 5042–5051.
Olayioye MA, Neve RM, Lane HA and Hynes NE. . 2000 EMBO J. 19: 3159–3167.
Otsuka T, Jakubczak J, Vieira W, Bottaro DP, Breckenridge D, Larochelle WJ and Merlino G. . 2000 Mol. Cell. Biol. 20: 2055–2065.
Papoff G, Hausler P, Eramo A, Pagano MG, Di Leve G, Signore A and Ruberti G. . 1999 J. Biol. Chem. 274: 38241–38250.
Pawson T and Scott JD. . 1997 Science 278: 2075–2080.
Pinkas-Kramarski R, Shelly M, Glathe S, Ratzkin BJ and Yarden Y. . 1996 J. Biol. Chem. 271: 19029–19032.
Plowman GD, Green JM, Culouscou JM, Carlton GW, Rothwell VM and Buckley S. . 1993 Nature 366: 473–475.
Rameh LE and Cantley LC. . 1999 J. Biol. Chem. 274: 8347–8350.
Remy I, Wilson IA and Michnick SW. . 1999 Science 283: 990–993.
Riese DJ II and Stern DF. . 1998 Bioessays 20: 41–48.
Shak S. . 1999 Semin. Oncol. 26: 71–77.
Siegel RM, Frederiksen JK, Zacharias DA, Chan FK, Johnson M, Lynch D, Tsien RY and Lenardo MJ. . 2000 Science 288: 2354–2357.
Stein E, Lane AA, Cerretti DP, Schoecklmann HO, Schroff AD, Van Etten RL and Daniel TO. . 1998 Genes Dev. 12: 667–678.
Sweeney C, Lai C, Riese DJ II, Diamonti AJ, Cantley LC and Carraway KL III. . 2000 J. Biol. Chem. 275: 19803–19807.
Syed RS, Reid SW, Li C, Cheetham JC, Aoki KH, Liu B, Zhan H, Osslund TD, Chirino AJ, Zhang J, Finer-Moore J, Elliott S, Sitney K, Katz BA, Matthews DJ, Wendoloski JJ, Egrie J and Stroud RM. . 1998 Nature 395: 511–516.
Timms JF, Carlberg K, Gu H, Chen H, Kamatkar S, Nadler MJ, Rohrschneider LR and Neel BG. . 1998 Mol. Cell. Biol. 18: 3838–3850.
Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ and Yarden Y. . 1996 Mol. Cell. Biol. 16: 5276–5287.
Tzahar E, Pinkas-Kramarski R, Moyer JD, Klapper LN, Alroy I, Levkowitz G, Shelly M, Henis S, Eisenstein M, Ratzkin BJ, Sela M, Andrews GC and Yarden Y. . 1997 EMBO J. 16: 4938–4950.
van der Geer P and Pawson T. . 1995 Trends Biochem. Sci. 20: 277–280.
Weiss A and Schlessinger J. . 1998 Cell 94: 277–280.
Wilson IA and Jolliffe LK. . 1999 Curr. Opin. Struct. Biol. 9: 696–704.
Acknowledgements
This work was supported by grant CA71702 from the National Institutes of Health to KL Carraway. C Sweeney is supported by a grant from the Massachusetts Department of Public Health Breast Cancer Research Program.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sweeney, C., Carraway, K. Ligand discrimination by ErbB receptors: differential signaling through differential phosphorylation site usage. Oncogene 19, 5568–5573 (2000). https://doi.org/10.1038/sj.onc.1203913
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203913
Keywords
This article is cited by
-
Biased activation of the receptor tyrosine kinase HER2
Cellular and Molecular Life Sciences (2023)
-
A shocking protein complex
Nature (2016)
-
Prediction of functional phosphorylation sites by incorporating evolutionary information
Protein & Cell (2012)
-
The ERBB3 receptor in cancer and cancer gene therapy
Cancer Gene Therapy (2008)
-
Neuregulin3 alters cell fate in the epidermis and mammary gland
BMC Developmental Biology (2007)